David Stone Email

VP, Genetics and Target Identification . Cerevel Therapeutics

Current Roles

Employees:
336
Revenue:
$94.6M
About
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinsonᅢᄁ¬ツᆲ¬トᄁs, Alzheimerᅢᄁ¬ツᆲ¬トᄁs, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
Cerevel Therapeutics Address
222 Jacobs Street
Boston, MA
United States
Cerevel Therapeutics Email

Past Companies

Cerevel TherapeuticsVice President, Genetics and Target Identification
Cerevel Therapeutics, LLCHead of Genetics
MerckDirector of Neurogenetics

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.